On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...

Criswell and Dr. Abby Fleish, a pediatric endocrinologist at MaineHealth, are studying whether an older cholesterol-lowering ...

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs.  The ...

Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...

These three Boston-area biotechs are awaiting drug approvals from the U.S. Food and Drug Administration before the end of ...

VISALIA, Calif (KFSN) -- For the first time in over a decade, obesity rates in the US are down, from 39% to 37.7%. Meanwhile, ...